February 19, 2026
1 min read

Trump’s tariff threats, measured by manufacturing

In this episode of “The Top Line,” Fierce Pharma’s Fraiser Kansteiner speaks with Atradius’ Brady McKinney about how tariff pressures drove a 2025 manufacturing surge in pharma and why production is expected to stabilize in the years ahead.

Leave a Reply

Your email address will not be published.

Previous Story

5 Dietitians Share Their Top 9 Go-To High Protein Snacks

Next Story

Does the world need ‘guy-necologists’?

Previous Story

5 Dietitians Share Their Top 9 Go-To High Protein Snacks

Next Story

Does the world need ‘guy-necologists’?

Latest from Blog

ROFI Drives New Approach to Crop Nutrition

With input costs continuing to pressure farm budgets, some growers are making difficult decisions to reduce fertilizer application rates. While that strategy may ease upfront expenses, it is also accelerating a broader
Go toTop